chr15-33748227-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001036.6(RYR3):āc.8103T>Gā(p.Asn2701Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000434 in 1,613,514 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001036.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RYR3 | NM_001036.6 | c.8103T>G | p.Asn2701Lys | missense_variant | 54/104 | ENST00000634891.2 | NP_001027.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RYR3 | ENST00000634891.2 | c.8103T>G | p.Asn2701Lys | missense_variant | 54/104 | 1 | NM_001036.6 | ENSP00000489262.1 |
Frequencies
GnomAD3 genomes AF: 0.000290 AC: 44AN: 151780Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000562 AC: 14AN: 248938Hom.: 0 AF XY: 0.0000518 AC XY: 7AN XY: 135062
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461616Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 727084
GnomAD4 genome AF: 0.000290 AC: 44AN: 151898Hom.: 1 Cov.: 32 AF XY: 0.000256 AC XY: 19AN XY: 74232
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2021 | The c.8103T>G (p.N2701K) alteration is located in exon 54 (coding exon 54) of the RYR3 gene. This alteration results from a T to G substitution at nucleotide position 8103, causing the asparagine (N) at amino acid position 2701 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Epileptic encephalopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 06, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 461963). This variant has not been reported in the literature in individuals affected with RYR3-related conditions. This variant is present in population databases (rs192820783, gnomAD 0.05%). This sequence change replaces asparagine, which is neutral and polar, with lysine, which is basic and polar, at codon 2701 of the RYR3 protein (p.Asn2701Lys). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at